Navigation Links
Pilot Study Opens the Door for Avastin Use in Curative Setting for Women With Breast Cancer
Date:12/17/2007

Roche in collaboration with Genentech commit to large phase III adjuvant

clinical programme set to unlock Avastin's potential in early breast

SAN ANTONIO, Dec. 17 /PRNewswire/ -- According to new phase II study data, Avastin (bevacizumab) can proceed to be tested after breast cancer surgery in combination with anthracycline containing regimens. These findings pave the way for Avastin's use as a curative treatment for women with this devastating disease. Data presented today at the San Antonio Breast Cancer Symposium (SABCS) from the E2104 study showed that standard anthracycline-based chemotherapy (doxorubicin) can be added to Avastin after surgical removal of the breast tumour, without a concerning increase in the incidence of cardiac adverse events typically associated with this form of chemotherapy.

These data support the commencement of phase III adjuvant breast cancer clinical programme which will include over 10,000 patients with early stage breast cancer. Avastin already offers women with late-stage (metastatic) breast cancer the chance to live twice as long without their disease progressing (1).

"The unique way Avastin works also lends itself for use in women with earlier stages of breast cancer" said Dr Kathy Miller of Indiana University School of Medicine, USA and principal investigator of the E2104 study. "We now know that Avastin use in combination with anthracyclines does not result in concerning rates of cardiac dysfunction in the adjuvant setting and armed with this evidence Avastin's impact can be fully validated in a large worldwide phase III clinical trial programme."

Data from the E2104 study have shown that cardiac dysfunction is not a major concern with the treatment combination of Avastin and doxorubicin. As presented in SABCS, two patients with symptomatic congestive heart failure were reported in each of the 2 Avastin-containing treatment arms which included more than 100 patie
'/>"/>

SOURCE Roche
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Preliminary Results of Randomized Pilot Study Show Comparable Efficacy for OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) and Boston Scientifics Taxus(R) Stent in Patients at High Risk of Restenosis
2. PLC Systems Achieves Successful Early Conclusion of RenalGuard(TM) Pilot Safety Trial
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
7. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
10. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
11. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...wire-FirstCall/ -- Clarient, Inc. (Nasdaq: CLRT )...athologists, oncologists and the pharmaceutical in...ke presentations at two upcoming investor conferen... will be made at the Lazard Capital Markets Sixth ...sday, November 17. The conference will be held at ...
(Date:11/7/2009)...re/ -- Patients reported C1-esterase inhibitor (C1...ing acute swelling attacks at any body location fo...ing to data presented today at the 2009 American C... Annual Meeting. The results come from a self-repo... the ongoing, prospective, open label I nternatio...
(Date:11/6/2009)...rstCall/ -- Oxygen Biotherapeutics, Inc. (OTC Bull...y approved reverse split of its common stock will .... 9, 2009 on a 1-for-15 split-adjusted basis. Oxyg...he new symbol OXBT. The stock also will have a new... effective. ,, "This reverse split was overwhel...
Breaking Medicine Technology:Clarient to Present at Upcoming Healthcare Investor Conferences in New York City 2Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care 2Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care 3Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 2Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 3Prospect Therapeutics In Vitro Studies Demonstrate that GCS 100 Drug Binds to and Blocks the Effects of Galectin 3 48875 1Prospect Therapeutics In Vitro Studies Demonstrate that GCS 100 Drug Binds to and Blocks the Effects of Galectin 3 48875 2Angel MedFlight Provides Air Medical Transportation for Accident Victim Needing Transport from France to U S 48871 1Angel MedFlight Provides Air Medical Transportation for Accident Victim Needing Transport from France to U S 48871 2Angel MedFlight Provides Air Medical Transportation for Accident Victim Needing Transport from France to U S 48871 3Quest Diagnostics to Speak at the Jefferies 3rd Annual Healthcare Conference 48867 1
(Date:11/9/2009)... LEBANON, Tenn., Nov. 9 Health Con...nounced it will host their inaugural Hospital O.R....010 at the Marriott Renaissance Hotel in Nashville... more than 100 hospital operating room directors a... health systems in the country. Some of the confir...
(Date:11/9/2009)... DETROIT, Nov. 9 For th... Cancer Center has been selected the most preferre...according to a survey by the National Research Cor...gi-bin/prnh/20071106/KARMANOSLOGO ) ,, The ann...naire between September 2008 and August 2009. Surv...
(Date:11/9/2009)... didn,t answer question of why this is so, however...- After a lumpectomy, women with very dense breast...ffected breast, a new study shows. , Breast den...k of developing breast cancer, and experts have su...ated with an increased risk of cancer recurrence a...
(Date:11/9/2009)... ROCHESTER, Minn., Nov. 9 /PRNewswire-USNewswire/ ... surgery for vaginal prolapse dramatically red...e findings are being presented this week at the No...ociation in Scottsdale, Ariz. ,, (Logo: http... ) ,, VIDEO ALERT : Additional audio and vide...
(Date:11/9/2009)... - Parents Support Experimental Procedure for Pr...re-USNewswire/ -- For parents of children with can...ates have steadily improved for decades. Among the... cause infertility. ,, Boys diagnosed with ca...portunity to preserve their fertility: before unde...
Breaking Medicine News(10 mins):Health News:Health Connect Partners Hosts Hospital O.R. & Surgery Center Conference 2Health News:Karmanos Cancer Center Most Preferred Hospital for Cancer Care in Southeast Michigan, Third Consecutive Year 2Health News:Dense Breasts Raise Risk of Cancer Recurrence 2Health News:Dense Breasts Raise Risk of Cancer Recurrence 3Health News:Mayo Researchers Find Robotic Repair for Vaginal Prolapse Has Significant Benefits 2Health News:Mayo Researchers Find Robotic Repair for Vaginal Prolapse Has Significant Benefits 3Health News:For Young Boys With Cancer, Testicular Tissue Banking May Be Option to Preserve Fertility 2Health News:For Young Boys With Cancer, Testicular Tissue Banking May Be Option to Preserve Fertility 3Health News:For Young Boys With Cancer, Testicular Tissue Banking May Be Option to Preserve Fertility 4
...lood volume explains it , , TUESDAY, Nov. ...ve learned that they need to adjust the results of...in obese men, but now researchers think they know ...new study doesn,t definitively prove why overweigh...
...ressure, more weight loss, study finds , ,...tart a walking program for their health get more o...s their steps, a new study shows. , "People who us...ntist at Stanford University. "They also seem to l...
...nth, ARLINGTON, Va., Nov. 20 Thanks to homecare,...t the U.S. will celebrate,Thanksgiving and other h...r,homes. During November, which is National Homeca...ically sound,cost-effective care in a patient-pref...
...each children how to keep hands clean, MORRIS PLA...uts a hand in his/her nose or mouth. Considering t...r longer on surfaces like,cafeteria tables, doorkn... for Disease Control and Prevention (CDC),keeping ...
...R, Nov. 20 /PRNewswire-FirstCall/ - Cardiome Pharm...itiation of subject dosing in its,Phase 1 study of...ose-ranging study will measure the safety, tolerab... 24-hour continuous,intravenous infusion of GED-aP...
...on Optics,Corporation, Inc. (OTC Bulletin Board: P...sults on an unaudited basis for the first quarter ...st Quarter Operating Results Revenues -- Total re...ts the second highest quarterly revenue in six,yea...
Other Medicine News:Health News:Why Obese Men Post Lower PSA Levels 2Health News:Pedometer Pushes People to Walk More 2Health News:Thanks to Homecare, Millions of Older Americans Celebrate Thanksgiving and Other Holidays at Home 2Health News:Proper Hand Hygiene Is Key to Avoiding Illness During Cold and Flu Season 2Health News:Cardiome Initiates Phase 1 Study for GED-aPC 2Health News:Cardiome Initiates Phase 1 Study for GED-aPC 3Health News:Cardiome Initiates Phase 1 Study for GED-aPC 4Health News:Precision Optics Corporation Announces First Quarter Results and Receipt of Significant New Order 2Health News:Precision Optics Corporation Announces First Quarter Results and Receipt of Significant New Order 3Health News:Precision Optics Corporation Announces First Quarter Results and Receipt of Significant New Order 4Health News:Precision Optics Corporation Announces First Quarter Results and Receipt of Significant New Order 5Health News:Precision Optics Corporation Announces First Quarter Results and Receipt of Significant New Order 6
Premier Encore Mini C-Arm
KM-500 Hand-Held Auto Keratometer
Herrick Lacrimal Plugs
Khosla Cryo Ultra
Medicine Products: